Bio-Techne Corporation
TECH
$83.81
$0.9651.17%
| 03/31/2024 | 12/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 11.31% | -1.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.31% | -1.57% | |||
| Cost of Revenue | 3.53% | 3.38% | |||
| Gross Profit | 15.45% | -4.01% | |||
| SG&A Expenses | 2.63% | -0.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.02% | 0.48% | |||
| Operating Income | 43.65% | -9.74% | |||
| Income Before Tax | 82.96% | -32.63% | |||
| Income Tax Expenses | 103.06% | 512.68% | |||
| Earnings from Continuing Operations | 78.62% | -46.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 78.62% | -46.14% | |||
| EBIT | 43.65% | -9.74% | |||
| EBITDA | 27.45% | -7.31% | |||
| EPS Basic | 78.89% | -45.94% | |||
| Normalized Basic EPS | 45.40% | -6.96% | |||
| EPS Diluted | 82.35% | -45.16% | |||
| Normalized Diluted EPS | 44.85% | -6.23% | |||
| Average Basic Shares Outstanding | -0.14% | -0.38% | |||
| Average Diluted Shares Outstanding | 0.27% | -1.16% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.44% | 0.84% | |||
